Market Place
Sourcing Support
DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions
Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Teva to sell assets to reduce debt, lay-off 7,000 workers; Shkreli awaits sentence
This week in Phispers, we look at the growing troubles at Teva. The company plans to divest non-core
India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017
A review of the Drug Master Files (DMFs) submitted to the United
States Food and Drug Administration
J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative
This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk
Singh bros hit back at Daiichi in Ranbaxy case; New drug shortages legislation in Canada
This
week, Phispers brings you the latest twist in the Singh brothers-Daiichi 2008
Ranbaxy sell-off
US DMF filings indicate a robust API industry, with multiple first-to-file challenges
This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at
Phispers: Pfizer-Allergan end megamerger, GSK wants to make copying its drugs easier & more
This week, the
biggest news in the world of pharmaceuticals was the termination of the Pfizer-Allerg
Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs?
The year 2015 has gone down
in history as a record year for mergers and acquisitions in the pharmace
Generic challenges, the next first-to-files, GDUFA dues (FY 2016) and more
PharmaCompass has assessed the second quarter US Drug Master
File (DMFs) filings. In our view, with
